Search
Now showing items 21-30 of 70
HIV infection and tuberculosis in South Africa: an urgent need to escalate the public health response.
(Elsevier, 2009)
One of the greatest challenges facing post-apartheid South Africa is the control of the concomitant HIV and
tuberculosis epidemics. HIV continues to spread relentlessly, and tuberculosis has been declared a national ...
Antiretroviral therapy : challenges and options in South Africa.
(Elsevier., 2003)
No abstract available.
Achieving the health Millennium Development Goals for South Africa : challenges and priorities.
(Elsevier., 2009)
15 years after liberation from apartheid, South Africans are facing new challenges for which the highest calibre of
leadership, vision, and commitment is needed. The effect of the unprecedented HIV/AIDS epidemic has been ...
High titer HIV-1 V3-specific antibodies with broad reactivity but low neutralizing potency in acute infection and following vaccination.
(Elsevier, 2008)
Identifying the earliest neutralizing antibody specificities that are elicited following infection or vaccination
by HIV-1 is an important objective of current HIV/AIDS vaccine research. We have shown previously ...
Initial B-Cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia.
(American Society for Microbiology., 2008)
A window of opportunity for immune responses to extinguish human immunodeficiency virus type 1 (HIV-1) exists from the moment of transmission through establishment of the latent pool of HIV-1-infected cells. A critical ...
The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa.
(Lippincott Williams & Wilkins., 2004)
This study investigated the impact of prevalent and incident HSV-2 infection on the incidence of HIV-1 infection in a cohort of female commercial sex workers in KwaZulu-Natal, South Africa. Prior to a vaginal microbicide ...
The C3-V4 region is a major target of autologous neutralizing antibodies in human immunodeficiency virus type 1 subtype C Infection.
(American Society for Microbiology., 2008)
The early autologous neutralizing antibody response in human immunodeficiency virus type 1 (HIV-1) subtype C infections is often characterized by high titers, but the response is type specific with little to no cross-neutralizing ...
Adolescents and HIV clinical trials: ethics, culture, and context.
(Elsevier., 2007)
One quarter of HIV infections globally occur among young people 15-24 years of age and more than half of all new infections are to people younger than 25 years. Clearly, there is a need to identify and implement effective ...
Managing multiple and extensively drug-resistant tuberculosis and HIV.
(Informa Healthcare., 2007)
Global increases in multi-drug-resistant and extensively drug-resistant tuberculosis (TB), are threatening both TB and HIV treatment programs worldwide. Together, they raise concerns of a global epidemic of untreatable TB. ...
Pregnancies complicated by multidrug-resistant tuberculosis and HIV co-infection in Durban, South Africa.
(International Union against Tuberculosis and Lung Disease., 2006)
SETTING: Tertiary hospitals in KwaZulu Natal, South Africa. OBJECTIVE: To study the impact of multidrug-resistant
tuberculosis (MDR-TB) and human immunodeficiency virus-1 (HIV-1) co-infection during pregnancy on maternal ...